Home » Topics » BioWorld Science

BioWorld Science
RSS

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

July 2, 2018

ZYDG-2, a GPR40 agonist for potential treatment of type 2 diabetes

July 2, 2018

Phase Ib data on intravenous dexmedetomidine support BioXcel's development of sublingual BXCL-501

July 2, 2018

Thinning out fat cells

July 2, 2018

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

June 29, 2018

First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine

June 29, 2018

G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer

June 29, 2018

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

June 29, 2018

Novartis to spin off Alcon eye care devices business

June 29, 2018

Preliminary in vivo pharmacokinetics for [125I]p93 reported

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...